Incidence of De Novo Nonmelanoma Skin Tumors After Liver Transplantation for Alcoholic and Nonalcoholic Liver Diseases

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2505-2507

  Jimenez Romero C ^a   Manrique Municio, A ^a   Marques Medina E ^a   Colina, F ^a   Ortega Domene, P ^a   Gomez Sanz R ^a   Meneu Diaz, J C ^a   Abradelo de Usera, M ^a   Moreno Elola, A ^a   Moreno Gonzalez, E ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER SURGERY; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MALE; NONALCOHOLIC FATTY LIVER; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; SKIN TUMOR; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR DIAGNOSIS;

ADULT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LIVER DISEASES; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SUNLIGHT;

EID: 33750625239     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.065     Document Type: Article

References (17)

1. Jain A.B., Yee L.D., and Nalesnik M.A. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 66 (1998) 1193
2. Jonas S., Rayes N., and Neumann U. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 80 (1997) 1141
3. Haagsma E.B., Hagens V.E., and Schaapveld M. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34 (2001) 84
4. Mithoefer A.B., Supran S., and Freeman R.B. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transpl 8 (2002) 939
5. Belloch S., Berenguer M., and Prieto M. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years. Am J Transplant 4 (2004) 596
6. De Hertog S.A.E., Wensveen C.A.H., and Bastiaens M.T. Relation between smoking and skin cancer. J Clin Oncol 19 (2001) 231
7. Castelli E., Hrelia P., and Maffei F. Indicators of genetics damage in alcoholics: reversibility after alcohol abstinence. Hepatogastroenterology 46 (1999) 1664
8. Tollerud D.J., Clark J.W., and Brown L.M. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 139 (1989) 194
9. Ehlers S.L., Rodriguez J.R., and Widows M.R. Tobacco use before and after liver transplantation: a single center survey and implications for clinical practice and research. Liver Transpl 10 (2004) 412
10. Jiménez C., Rodri{dotless}́guez D., and Marqués E. De novo tumors after orthotopic liver transplantation. Transplant Proc 34 (2002) 297
11. DiGiovanna J.J. Posttransplantation skin cancer: scope of the problem, management, and role for systemic reinoid chemoprevention. Transplant Proc 30 (1998) 2771
12. Kelly D.M., Emre S., and Guy S.R. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 83 (1998) 1237
13. Hernández-Vallejo G., Jiménez C., and Vicente J.C. Incidence and risk factors for cancer after liver transplantation. Crit Rev in Oncolo Hematolo 56 (2005) 87
14. Jain A., DiMartini A., and Kashyap R. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 70 (2000) 1335
15. Levy M., Backman L., and Husberg B. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 25 (1993) 1397
16. Dantal J., Hourmant M., and Cantarovich D. Effect of long-term immunosuppression in kidney graft recipients on cancer incidence: randomized comparison of two cyclosporine regimens. Lancet 351 (1998) 623
17. Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 23 (1991) 1101